School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, South Korea.
College of Pharmacy, Inje University, 607 Obang-dong, Gimhae, Gyungnam, 621-749, South Korea.
Cell Death Differ. 2022 Jun;29(6):1199-1210. doi: 10.1038/s41418-021-00911-y. Epub 2022 Jan 1.
Ninjurin1 (Ninj1), an adhesion molecule, regulates macrophage function in hyaloid regression, multiple sclerosis, and atherosclerosis. However, its biological relevance and the mechanism underlying its function in vascular network integrity have not been studied. In this study, we investigated the role of Ninj1 in physiological (postnatal vessel formation) and pathological (endotoxin-mediated inflammation and diabetes) conditions and developed a strategy to regulate Ninj1 using specific micro (mi)RNAs under pathological conditions. Ninj1-deficient mice exhibited decreased hyaloid regression, tip cell formation, retinal vascularized area, recruitment of macrophages, and endothelial apoptosis during postnatal development, resulting in delayed formation of the vascular network. Five putative miRNAs targeting Ninj1 were selected using the miRanda algorithm and comparison of expression patterns. Among them, miR-125a-5p showed a profound inhibitory effect on Ninj1 expression, and miR-125a-5p mimic suppressed the cell-to-cell and cell-to-matrix adhesion of macrophages and expression of pro-inflammatory factors mediated by Ninj1. Furthermore, miR-125a-5p mimic inhibited the recruitment of macrophages into inflamed retinas in endotoxin-induced inflammation and streptozotocin-induced diabetes in vivo. In particular, miR-125a-5p mimic significantly attenuated vascular leakage in diabetic retinopathy. Taken together, these findings suggest that Ninj1 plays a pivotal role in macrophage-mediated vascular integrity and that miR-125a-5p acts as a novel regulator of Ninj1 in the management of inflammatory diseases and diabetic retinopathy.
Ninjurin1 (Ninj1),一种黏附分子,调节了细胞在玻璃膜血管退化、多发性硬化症和动脉粥样硬化中的功能。然而,其生物学相关性及其在血管网络完整性中的功能机制尚未得到研究。在这项研究中,我们研究了 Ninj1 在生理(产后血管形成)和病理(内毒素介导的炎症和糖尿病)条件下的作用,并开发了一种在病理条件下使用特定微(mi)RNA 调节 Ninj1 的策略。Ninj1 缺陷型小鼠在出生后发育过程中表现出玻璃膜血管退化、尖端细胞形成、视网膜血管化面积、巨噬细胞募集和内皮细胞凋亡减少,导致血管网络形成延迟。使用 miRanda 算法和表达模式比较选择了 5 个可能靶向 Ninj1 的 miRNA。其中,miR-125a-5p 对 Ninj1 表达具有显著的抑制作用,miR-125a-5p 模拟物抑制了巨噬细胞的细胞间和细胞基质黏附以及 Ninj1 介导的促炎因子的表达。此外,miR-125a-5p 模拟物抑制了内毒素诱导的炎症和链脲佐菌素诱导的糖尿病体内炎症性视网膜中巨噬细胞的募集。特别是,miR-125a-5p 模拟物显著减轻了糖尿病视网膜病变中的血管渗漏。综上所述,这些发现表明 Ninj1 在巨噬细胞介导的血管完整性中起关键作用,miR-125a-5p 作为 Ninj1 的新型调节剂参与了炎症性疾病和糖尿病性视网膜病变的治疗。